In conclusion, our findings strongly suggest that RHEBL1 and RNPC3 are potential targets for Polyphyllin VI and Protodioscin in the treatment of non-small cell lung cancer, and may also be candidate diagnostic genes for non-small cell lung cancer-related prognosis. Here, RNPC3 is linked to non-small cell lung carcinoma.